| Literature DB >> 19122111 |
Stephen Salloway1, Stephen Correia.
Abstract
Basic research is bringing a much-needed infusion of optimism and urgency to the clinical diagnosis and treatment of Alzheimer disease. Some of its risk factors may be modifiable, and although current drugs offer only modest benefit, true disease-modifying drugs are on the horizon. This review is aimed at primary care physicians, who are the first clinicians to see patients with Alzheimer disease and are responsible for their ongoing care throughout the course of their dementia.Entities:
Mesh:
Year: 2009 PMID: 19122111 DOI: 10.3949/ccjm.76a.072178
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321